Small Molecules
10 October 2016
Nicox Receives Complete Response Letter from the FDA Related to GMP on NDA for AC-1709 October 2016
Fulvestrant Demonstrates Progression-Free Survival Advantage in 1st Line Advanced Breast Cancer9 October 2016
Phase III nintedanib trial results in patients with metastatic colorectal cancer announced at ESMO 20169 October 2016
Novartis ALK+ metastatic NSCLC therapy Zykadia® extends progression-free survival beyond 18 months in Phase II study9 October 2016
U.S. FDA approves Carnexiv™ (carbamazepine) injection as intravenous replacement therapy for oral carbamazepine formulations5 October 2016
Karus Therapeutics Announces First Lymphoma Patients Dosed with KA2237 in Clinical Study at the MD Anderson Cancer CenterNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports